JOHNSON JOHN SEC Filings

Filed On	Filing
26 Jun 2026	Form 4: Johnson John, Director · AxoGen, Inc. Granted 4,392 Restricted Stock Units
23 Jun 2026	Form 4: Johnson John, Director · AxoGen, Inc. Received 14,150 shares by exercise or conversion · Acquired 14,150 Restricted Stock Units (Option Exercise/Conversion)
05 Jun 2026	Form 4: Johnson John, Director · Xeris Biopharma Holdings, Inc. Sold 15,000 shares ($91.4K) · Received 24,193 shares as a grant or award · Granted 32,996 Stock Option (Right to Buy) ($203K)
04 Jun 2026	144
26 May 2026	Form 4: Johnson John, Director · Verastem Inc Received 36,000 shares as a grant or award
08 May 2026	Form 4: Johnson John, Director · AxoGen, Inc. Received 11,050 shares by exercise or conversion ($77.8K) · Sold 11,050 shares ($478K)
07 May 2026	144
19 Dec 2025	144
19 Dec 2025	Form 4: Johnson John, Director · Xeris Biopharma Holdings, Inc. Sold 135,400 shares ($977K)
10 Dec 2025	Form 4: Johnson John, Director · AxoGen, Inc. Sold 23,693 shares ($740K) · Received 11,891 shares by exercise or conversion ($74.9K) · Received 8,545 shares by exercise or conversion ($53.8K) · 1 more
09 Dec 2025	144
08 Dec 2025	144
15 Aug 2025	Form 4: Johnson John, Director · Xeris Biopharma Holdings, Inc. Sold 107,500 shares ($786K)
13 Aug 2025	144
20 Jun 2025	Form 4: Johnson John, Director · AxoGen, Inc. Granted 14,150 Restricted Stock Units
11 Jun 2025	Form 4: Johnson John, Director · AxoGen, Inc. Sold 4,073 shares ($43.2K)
04 Jun 2025	Form 4: Johnson John, Director · Xeris Biopharma Holdings, Inc. Received 50,000 shares as a grant or award
27 May 2025	Form 4: Johnson John, Director · Verastem Inc Received 8,333 shares as a grant or award · Granted 12,500 Stock Option (right to buy)
20 Dec 2024	Form 4: Johnson John, Director · Applied Therapeutics, Inc. Received 500,000 shares as a grant or award · Granted 1,000,000 Stock Option (Right to Buy)
20 Dec 2024	Form 3: Johnson John, Director · Applied Therapeutics, Inc. No securities owned

Comments